Research identifies new mechanisms behind sarcopenia and COPD-related muscle loss

Research published in the journal Aging Cell has provided new insights into sarcopenia, the age-related loss of muscle mass and strength. A review article suggests that sarcopenia results from disrupted communication between various cell types—including muscle stem, stromal, immune, vascular, and nerve cells—rather than the failure of individual cell types alone.

In studies involving older mice, researchers observed that certain muscle stem cells lose the ability to return to a reversible resting state. This process is linked to the protein NDRG1, which inhibits the mTOR signaling pathway essential for cell growth and regeneration.

Additionally, a separate study in Aging Cell identified a specific molecular mechanism affecting patients with Chronic Obstructive Pulmonary Disease (COPD) and associated sarcopenia. The research highlights the role of the enzyme Prodh2, which is elevated in these patients. The study describes how the inflammatory messenger TNF-α activates Prodh2 via the p53 protein, leading to the production of mitochondrial reactive oxygen species and the release of mitochondrial DNA. This sequence activates the cGAS/STING signaling pathway, which subsequently damages muscle progenitor cells.